• an endoscopic defect repair and tumor debulking were performed.
• a second endoscopic defect repair was performed for residual liquorea • for visual field defect cabergoline was returned in the dose of 1tablet (0.5 mg) per week Prolactinomas are the most common hormonally active tumours of the pituitary. The treatment of choice in macroprolactinomas are dopaminergic agonists (cabergoline) that both decrease prolactin levels and shrink the tumour. Rarely, dangerous complications can arise after a quick reduction of the tumour's size.
Pacient no 1 -CT scan after treatmentpneumocephalus Pacient no 1 -MR before treatment with cabergolin T2 scan after a few months
